Cameron Durrant

Aug 30, 2010 — PRNewswire-FirstCall/ - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that Dr. Cameron Durrant, the company's ...

Hi-Tech Pharmacal also announced the appointment of Cameron Durrant as the new Chief Executive Officer for its ECR Pharmaceuticals ...

View the profiles of professionals named "Cameron Durrant" on LinkedIn. There are 10+ professionals named "Cameron Durrant", who use LinkedIn to exchange ...

View Dr. Cameron Durrant MD, MBA'S profile on LinkedIn, the world's largest professional community. Dr. Cameron has 0 jobs jobs listed on their profile.

View Dr. Cameron Durrant MD, MBA's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Cameron Durrant ...

Declaring a weakness is actually a strength." "You acquire more power by giving it up." Paradoxes like these are Cameron Durrant's ...

... filing by the company once led by widely reviled investor and pharmaceutical executive Martin Shkreli. The Brisbane company would make one-time equity awards of at least $300,000 each to directors Ronald Barliant and David Moradi and at least $100,000 to Chairman and CEO Dr. Cameron Durrant.

Jun 20, 2013 ... Hi-Tech Pharmacal also announced the appointment of Cameron Durrant as the new Chief Executive Officer for its ECR Pharmaceuticals ...

30, 2010– Anavex Life Sciences Corp., (“ANAVEX” or the “Company”) (OTCBB: AVXL) is pleased to announce that Dr. Cameron Durrant, the ...

Chairman, CEO & Interim CFO and Chief Accounting Officer, Humanigen, Inc. ... Dr. Cameron Durrant, MD, MBA, is the Chairman and Chief Executive Officer of Humanigen, since January 2016 and serves as its Interim Chief Financial Officer and Chief Accounting Officer since June 28, 2019.